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  Carboquone preparations， Es（luinone fbr injection and Esquinone inj ection， werc infused into
the b互adder to investigate their ahtitumor activity and inactivation of carboquone in urine in 72 patieロts
with superficial bladder tu卑ors．．
  Thc fbllowing．conclusions Were qbtained：．
  1。Stability of carboquone was high玉y dePendent o耳 pH of the u血e mixcd with it．． Its inactiva－
tion was marked at acidic pH． Reduction of the amount of urine during infusion and use of a larger
amount of d圭luent are量mportant to prevent the inactivation． of 6arboquone、
  2． Intra－vesi¢al infusion of carboquone was eセaluated to be effective in 51．4％patients。
  3．lNo spccial difference in effective耳ess．was負）μnd between Esquinone fbr切ection and Esqu三一
   ロ             の．none I㎎ectlon・
  生 No difference i耳 effectiveness was f（）und between the patients with primary tumors and thosc
with recurrent tumors．
  5．As fbr side．effects， Esquinone fbr垣lection and ESquinone injectio皿caused irritant symptoms
of the bladder in 36．4 and 52．0％ of patients， respcctively．












































































5A（ 2． 5ml ）
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Fig・1・carboquone溶液と健康人尿混合時のcarboquoneの安定性
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Table 3 ． pH of mixtures of Carboquone dilutions and norma］
    urine and the safety of Carboquone
（イ）Case of urine mixtures with a pH 5．6
混合液のpHとCarboquoneの残存率（％）
混 合 方 法
混合後（尿）pH
     1 時     3





















（ロ）Case of urine mixtures with a pH of 6．0
混合液のpHとCarboquoneの残存率（％）
混 合 方 法
混合後（尿）pH
     l 時
     3





















Table 4 ． Number of patients given various intraeystic injections













計 6 43 3 20 72
Table 5 ． Antitumor results by intracystic injection of Esquinon
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Table 6 ． Size of tumor and antitumor results














































































計 13 12 25 50
Table 7 ． Antitumor results for single and multiple tumors
著効 （％） 有効 （％） 無効 （％） 計







計 3 9 10 22







計 13 ユ2 25 50
Table 8． AntitumQr resultsi for initial and recurrent tumors












計 3 9 10 22




















    小野・ほか：膀胱腫蕩・carbOquone注入療法
Table 9 ． lncidence of bladder irritation in accordance with
     total number of injections
625
総：注入
回  数 症例数
膀胱刺激  血 尿
症状なし 排尿痛
頻 尿  刺激説状













































































注射用エスキノン    ／ エスキノン注射二
一






  注入前     注入後 注入前     注入後
Fig・5・carboquone膀胱腔内注入前後の末1











 注入前        注入後  注入前      注入後
Fig・4・carbOquone膀胱腔内注入前後の末
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